ResearcherSamsung Medical CenterNo recent work listed
Dong Wook Choi
Matched on ORCID iD 0000-0002-0751-7841; OpenAlex author ID A5101879211. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 25
2011: 1 paper · 2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: 2 papers · 2018: none · 2019: none · 2020: 2 papers · 2021: 1 paper
Papers 7
- Appraisal of 5-year recurrence-free survival after surgery in pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/jhbp.815↗
- Clinical outcomes of pancreaticoduodenectomy for pancreatic ductal adenocarcinoma depending on preservation or resection of pylorus. Co-author DOI 10.14701/ahbps.2020.24.3.269↗
- Predictive Nomogram for Early Recurrence after Pancreatectomy in Resectable Pancreatic Cancer: Risk Classification Using Preoperative Clinicopathologic Factors. Co-author DOI 10.3390/cancers12010137↗
- Large-scale clinical validation of biomarkers for pancreatic cancer using a mass spectrometry-based proteomics approach. Co-author DOI 10.18632/oncotarget.17463↗
- Extended versus peripancreatic lymph node dissection for the treatment of left-sided pancreatic cancer. Last author DOI 10.4174/astr.2017.92.6.411↗
- The value of positron emission tomography/computed tomography for evaluating metastatic disease in patients with pancreatic cancer. Last author DOI 10.1097/mpa.0b013e318252f4f5↗
- A prognostic model to predict clinical outcomes with first-line gemcitabine-based chemotherapy in advanced pancreatic cancer. Co-author DOI 10.1159/000328449↗
Closest collaborators
The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jin Seok Heo · 5 shared papers, 2017–2021 · strength 0.55
- Paper Appraisal of 5-year recurrence-free survival after surgery in pancreatic ductal adenocarcinoma. DOI 10.1002/jhbp.815↗
- Paper Clinical outcomes of pancreaticoduodenectomy for pancreatic ductal adenocarcinoma depending on preservation or resectio… DOI 10.14701/ahbps.2020.24.3.269↗
- Paper Predictive Nomogram for Early Recurrence after Pancreatectomy in Resectable Pancreatic Cancer: Risk Classification Usin… DOI 10.3390/cancers12010137↗
- In Woong Han · 3 shared papers, 2020–2021 · strength 0.39
- Paper Appraisal of 5-year recurrence-free survival after surgery in pancreatic ductal adenocarcinoma. DOI 10.1002/jhbp.815↗
- Paper Clinical outcomes of pancreaticoduodenectomy for pancreatic ductal adenocarcinoma depending on preservation or resectio… DOI 10.14701/ahbps.2020.24.3.269↗
- Paper Predictive Nomogram for Early Recurrence after Pancreatectomy in Resectable Pancreatic Cancer: Risk Classification Usin… DOI 10.3390/cancers12010137↗
- Sang Hyun Shin · 3 shared papers, 2020–2021 · strength 0.39
- Paper Appraisal of 5-year recurrence-free survival after surgery in pancreatic ductal adenocarcinoma. DOI 10.1002/jhbp.815↗
- Paper Clinical outcomes of pancreaticoduodenectomy for pancreatic ductal adenocarcinoma depending on preservation or resectio… DOI 10.14701/ahbps.2020.24.3.269↗
- Paper Predictive Nomogram for Early Recurrence after Pancreatectomy in Resectable Pancreatic Cancer: Risk Classification Usin… DOI 10.3390/cancers12010137↗
- Youngju Ryu · 2 shared papers, 2020 · strength 0.25
- Paper Clinical outcomes of pancreaticoduodenectomy for pancreatic ductal adenocarcinoma depending on preservation or resectio… DOI 10.14701/ahbps.2020.24.3.269↗
- Paper Predictive Nomogram for Early Recurrence after Pancreatectomy in Resectable Pancreatic Cancer: Risk Classification Usin… DOI 10.3390/cancers12010137↗
- Naru Kim · 2 shared papers, 2020 · strength 0.25
- Paper Clinical outcomes of pancreaticoduodenectomy for pancreatic ductal adenocarcinoma depending on preservation or resectio… DOI 10.14701/ahbps.2020.24.3.269↗
- Paper Predictive Nomogram for Early Recurrence after Pancreatectomy in Resectable Pancreatic Cancer: Risk Classification Usin… DOI 10.3390/cancers12010137↗
- Seong Ho Choi · 2 shared papers, 2017 · strength 0.16
- So Jeong Yoon · 1 shared paper, 2021 · strength 0.14
- Ji Hye Jung · 1 shared paper, 2021 · strength 0.14
- Dae Wook Hwang · 1 shared paper, 2020 · strength 0.13
- Yeon Jin Kim · 1 shared paper, 2020 · strength 0.13
- Huisong Lee · 1 shared paper, 2017 · strength 0.10
- Jong Kyun Lee · 2 shared papers, 2012–2017 · strength 0.09
- Paper Large-scale clinical validation of biomarkers for pancreatic cancer using a mass spectrometry-based proteomics approach. DOI 10.18632/oncotarget.17463↗
- Paper The value of positron emission tomography/computed tomography for evaluating metastatic disease in patients with pancre… DOI 10.1097/mpa.0b013e318252f4f5↗
- Kwang Hyuck Lee · 2 shared papers, 2012–2017 · strength 0.09
- Paper Large-scale clinical validation of biomarkers for pancreatic cancer using a mass spectrometry-based proteomics approach. DOI 10.18632/oncotarget.17463↗
- Paper The value of positron emission tomography/computed tomography for evaluating metastatic disease in patients with pancre… DOI 10.1097/mpa.0b013e318252f4f5↗
- Young Suk Park · 2 shared papers, 2011–2017 · strength 0.08
- Paper Large-scale clinical validation of biomarkers for pancreatic cancer using a mass spectrometry-based proteomics approach. DOI 10.18632/oncotarget.17463↗
- Paper A prognostic model to predict clinical outcomes with first-line gemcitabine-based chemotherapy in advanced pancreatic c… DOI 10.1159/000328449↗
- Joon-Oh Park · 1 shared paper, 2017 · strength 0.06
- Soo‐Youn Lee · 1 shared paper, 2017 · strength 0.06
- Kee‐Taek Jang · 1 shared paper, 2017 · strength 0.06
- Jisook Park · 1 shared paper, 2017 · strength 0.06
- Eunjung Lee · 1 shared paper, 2017 · strength 0.06
- Hyung‐Doo Park · 1 shared paper, 2017 · strength 0.06
- Kyu Taek Lee · 2 shared papers, 2011–2012 · strength 0.05
- Paper The value of positron emission tomography/computed tomography for evaluating metastatic disease in patients with pancre… DOI 10.1097/mpa.0b013e318252f4f5↗
- Paper A prognostic model to predict clinical outcomes with first-line gemcitabine-based chemotherapy in advanced pancreatic c… DOI 10.1159/000328449↗
- Mi Jin Kim · 1 shared paper, 2012 · strength 0.03
- Ho Yeong Lim · 1 shared paper, 2011 · strength 0.02
- Jun Ho Yi · 1 shared paper, 2011 · strength 0.02
- Joon Oh Park · 1 shared paper, 2011 · strength 0.02
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.